4//SEC Filing
Derynck Mika K 4
Accession 0001415889-24-004014
CIK 0001672619other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:48 PM ET
Size
5.6 KB
Accession
0001415889-24-004014
Insider Transaction Report
Form 4
Derynck Mika K
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-13+16,835→ 16,835 totalExercise: $14.85Exp: 2034-02-12→ Common Stock (16,835 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001865125
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 8:48 PM ET
- Size
- 5.6 KB